Current stage in inflammatory bowel disease: What is next?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 40

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 28, 2015; 21(40): 11282-11303
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11282

Table 5 Risk factors associated to secondary failure or loss of response

Individual differences in bioavailability and pharmacokinetics

Symptoms not due to inflammatory bowel disease

Lack of adherence to therapy

Drug loss in stools

Intermittent treatments

Non-inflammatory symptoms

Structuring disease pattern

Smoking

Development of antibodies

Citation: Gómez-Gómez GJ, Masedo &, Yela C, Martínez-Montiel MDP, Casís B. Current stage in inflammatory bowel disease: What is next? World J Gastroenterol 2015; 21(40): 11282-11303
URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11282.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i40.11282

Gómez-Gómez GJ, Masedo &, Yela C, Martínez-Montiel MDP, Casís B. Current stage in inflammatory bowel disease: What is next? World J Gastroenterol 2015; 21(40): 11282-11303 [PMID: 26525013 DOI: 10.3748/wjg.v21.i40.11282]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.